Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 3/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11028664 | 0.85 | SLC6A4 (0.37) | SLC6A4SLC6A3 | |
| SCHEMBL6753578 | 0.84 | SLC6A3 (0.36) | SLC6A4SLC6A3ALDH1A1 | |
| SCHEMBL6751683 | 0.83 | SLC6A4 (0.36) | SLC6A4SLC6A3 | |
| SCHEMBL29214529 | 0.81 | SLC6A3 (0.37) | SLC6A4SLC6A3ALDH1A1APOBEC3G | |
| SCHEMBL6752426 | 0.74 | — | — | |
| SCHEMBL3665645 | 0.70 | APOBEC3G (0.36) | MEN1KMT2AALDH1A1HPGDAPOBEC3G | |
| SCHEMBL8963206 | 0.69 | CNR1 (0.37) | SLC6A4SLC6A3 | |
| SCHEMBL28984526 | 0.68 | ALDH1A1 (0.39) | SLC6A4SLC6A3ALDH1A1HPGD | |
| SCHEMBL1243389 | 0.67 | ALDH1A1 (0.36) | SLC6A4SLC6A3MEN1KMT2AALDH1A1 | |
| SCHEMBL29016435 | 0.67 | PDK2 (0.36) | SLC6A4SLC6A3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6703083-B2 | LIQUID CRYSTALLINE COMPOUND HAVING A SIH3 GROUP AT AN END | CHISSO CORPORATION (JP) | 2004-03-09 | — | — | US | disclosed |
| US-20030168632-A1 | Silicon compound, liquid cystal composition and liquid crystal display | CHISSO PETROCHEMICAL CORPORATION (JP) | 2003-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030168632-A1 | Silicon compound, liquid cystal composition and liquid crystal display | CLCN2, HCN2, PKD2 | SLC6A4 2313/4885SLC6A3 1550/4885MEN1 310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.